Venture_Socks_RZ_RGB_300dpi(2)_edited.pn

WINNERS

Inositec

2015

Health & Nutrition

Inositec AG is developing first-in-class treatments for soft tissue calcification disorders based on its proprietary Inositune™ platform of inositol phosphate (IP6) analogs. The company’s lead programs address vascular and renal calcification disorders, including orphan indications.

Venture_GreenLayer_v2_edited.png